查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1607134

G 蛋白偶聯受體市場：按產品類型、檢測類型、應用分類 - 2025-2030 年全球預測

G-Protein Coupled Receptors Market by Product (Cell Culture Reagents, Cell Lines, Detection Kits), Assay Type (Calcium Functional Assays, cAMP Functional Assays, Internalization Assays), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年G蛋白偶聯受體市場價值為33.1億美元，預計2024年將達到35.1億美元，複合年成長率為6.27%，2030年將達到50.7億美元，預計將達到1000萬美元。

G 蛋白偶聯受體 (GPCR) 是一個龐大的細胞表面受體家族，在許多生理過程中都很重要，這使得它們對於藥物發現和開發至關重要。 GPCR市場範圍涵蓋製藥、生物技術和學術領域，其在癌症、心血管疾病和神經系統疾病等多種疾病的治療中發揮重要作用。高通量篩檢技術和先進的計算模型能夠更精確地定位和理解 GPCR 功能，從而增強在藥物發現和個人化醫療中的應用。最終用途領域主要包括製藥公司、研究機構和受託研究機構。市場成長主要由慢性病盛行率上升、研發投資增加以及基因組學和蛋白​​質組學技術進步所推動。 GPCR 研究與人工智慧和機器學習的整合為更具預測性和針對性的治療提供了機會，為個人化醫療和新穎的治療方法鋪平了道路。儘管有這些機遇，市場仍面臨高成本、複雜的監管要求以及理解 GPCR 結構的技術限制等挑戰。此外，激烈的競爭和對專業人員的需求也阻礙了成長。克服這些障礙的策略包括學術界和工業界的共同努力、增加對基礎研究的資助以及培育技術共用的夥伴關係。基於結構的藥物設計和變構調節的創新是有前景的業務成長領域。總體而言，GPCR 市場正在蓬勃發展，全面了解受體功能對於挖掘其潛力至關重要。優先考慮創新、策略聯盟和適應性監管環境的公司可能會在這個不斷變化的環境中獲得顯著的利益。

主要市場統計
基準年[2023] 33.1億美元
預測年份 [2024] 35.1億美元
預測年份 [2030] 50.7億美元
複合年成長率（%） 6.27%

市場動態：快速發展的 G 蛋白偶聯受體市場的關鍵市場洞察

G 蛋白偶聯受體市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球心血管疾病增加
    • 增加開發新藥物和治療方法的支出
    • 正在進行的減輕癌症負擔的研究工作
  • 市場限制因素
    • G 蛋白偶聯受體 (GPCR) 相關的高成本
  • 市場機會
    • 核准的新藥和治療方法數量迅速增加
    • G蛋白偶聯受體分子認知新進展
  • 市場挑戰
    • 缺乏經過訓練的專業人員和受過訓練的受試者的專業知識，加上嚴格的核准標準

波特五力：駕馭 G 蛋白偶聯受體市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 G 蛋白偶聯受體市場的外部影響

外部宏觀環境因素在塑造 G 蛋白偶聯受體市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解G蛋白偶聯受體市場的競爭格局

G 蛋白偶聯受體市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣G蛋白偶聯受體市場供應商績效評估

FPNV 定位矩陣是評估 G 蛋白偶聯受體市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製 G 蛋白偶聯受體市場的成功之路

G 蛋白偶聯受體市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心血管疾病在世界範圍內呈上升趨勢
      • 增加開發新藥物和治療方法的支出
      • 正在進行的減輕癌症負擔的研究活動
    • 抑制因素
      • G 蛋白偶聯受體 (GPCR) 相關的高成本
    • 機會
      • 新藥和新治療方法的監管核准迅速增加
      • G蛋白偶聯受體分子認知新進展
    • 任務
      • 缺乏熟練的專業人員和訓練有素的主題專業知識以及嚴格的核准標準
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 G蛋白偶聯受體市場：依產品

  • 細胞培養試劑
  • 細胞株
  • 檢測試劑套件
  • 配體

第 7 章按檢測類型分類的 G 蛋白偶聯受體市場

  • 鈣功能測定
  • cAMP功能測定
  • 內化分析
  • 放射性配體結合和 GTPYS 功能測定
  • 運輸分析
  • B-抑制蛋白功能測定

第8章 G蛋白偶聯受體市場：依應用分類

  • 癌症研究
  • 心血管檢查
  • 中樞神經系統檢查
  • 發炎檢查
  • 代謝研究
  • 呼吸道檢查

第9章 美洲G蛋白偶聯受體市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太G蛋白偶聯受體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲G蛋白偶聯受體市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abalone Bio, Inc.
  • Abcam PLC
  • Addex Therapeutics
  • Becton, Dickinson and Company
  • BioInvenu,Inc.
  • Cisbio Bioassays SAS
  • Confo Therapeutics
  • Corning Incorporated
  • Crinetics Pharmaceuticals, Inc.
  • Domain Therapeutics SA
  • Enzo Life Sciences, Inc.
  • Escient Pharmaceuticals
  • Eurofins Scientific SE
  • Merck KGaA
  • Molecular Devices, LLC
  • OKYO Pharma, Limited
  • Orion Biotechnology
  • OSE Immunotherapeutics
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN GmbH
  • Septerna
  • Sosei Group Corporation
  • Tectonic Therapeutic
  • Teon Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec
Product Code: MRR-521BAA36EDBA

The G-Protein Coupled Receptors Market was valued at USD 3.31 billion in 2023, expected to reach USD 3.51 billion in 2024, and is projected to grow at a CAGR of 6.27%, to USD 5.07 billion by 2030.

G-Protein Coupled Receptors (GPCRs) are a vast family of cell surface receptors crucial in many physiological processes, making them vital in drug discovery and development. The GPCR market's scope encompasses pharmaceuticals, biotechnology, and the academic sector, necessitated by its role in treating a wide array of diseases such as cancer, cardiovascular disorders, and neurological conditions. The high-throughput screening techniques and advanced computational modeling have enabled more precise targeting and understanding of GPCR functions, thereby enhancing applications in drug discovery and personalized medicine. End-use segments mainly include pharmaceutical companies, research institutions, and contract research organizations. Market growth is primarily driven by the rising prevalence of chronic diseases, increasing investment in research and development, and technological advancements in genomics and proteomics. The integration of artificial intelligence and machine learning with GPCR research offers opportunities for more predictive and targeted therapies, paving the way for personalized medicine and novel therapeutic approaches. Despite these opportunities, the market faces challenges such as high costs associated with R&D, complex regulatory requirements, and technical limitations in understanding GPCR structures. Moreover, the high competition and need for specialized personnel can also impede growth. Strategies to overcome these obstacles include collaborative efforts between academia and industry, increased funding for basic research, and fostering partnerships for technology sharing. Innovations in structure-based drug design and allosteric modulation represent promising areas for business growth. Overall, the GPCR market is dynamic and expanding, with a comprehensive understanding of receptor functions being integral to harnessing its potential. Companies that prioritize innovation, strategic collaborations, and adaptive regulatory strategies stand to benefit significantly in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 3.31 billion
Estimated Year [2024] USD 3.51 billion
Forecast Year [2030] USD 5.07 billion
CAGR (%) 6.27%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving G-Protein Coupled Receptors Market

The G-Protein Coupled Receptors Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of cardiovascular diseases across the globe
    • Increasing expenditure for the development of novel pharmaceutical drugs and therapies
    • Ongoing research activities to reduce the cancer burden
  • Market Restraints
    • Associated high cost with G-protein coupled receptors (GPCRs)
  • Market Opportunities
    • Surge in the number of regulatory approvals for novel drugs and therapies
    • Emerging advances in the molecular understanding of G protein-coupled receptors
  • Market Challenges
    • Lack of skilled professionals or trained subject expertise coupled with stringent approval norms

Porter's Five Forces: A Strategic Tool for Navigating the G-Protein Coupled Receptors Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the G-Protein Coupled Receptors Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the G-Protein Coupled Receptors Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the G-Protein Coupled Receptors Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the G-Protein Coupled Receptors Market

A detailed market share analysis in the G-Protein Coupled Receptors Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the G-Protein Coupled Receptors Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the G-Protein Coupled Receptors Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the G-Protein Coupled Receptors Market

A strategic analysis of the G-Protein Coupled Receptors Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the G-Protein Coupled Receptors Market, highlighting leading vendors and their innovative profiles. These include Abalone Bio, Inc., Abcam PLC, Addex Therapeutics, Becton, Dickinson and Company, BioInvenu,Inc., Cisbio Bioassays SAS, Confo Therapeutics, Corning Incorporated, Crinetics Pharmaceuticals, Inc., Domain Therapeutics SA, Enzo Life Sciences, Inc., Escient Pharmaceuticals, Eurofins Scientific SE, Merck KGaA, Molecular Devices, LLC, OKYO Pharma, Limited, Orion Biotechnology, OSE Immunotherapeutics, PerkinElmer Inc., Promega Corporation, QIAGEN GmbH, Septerna, Sosei Group Corporation, Tectonic Therapeutic, Teon Therapeutics, Inc., Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the G-Protein Coupled Receptors Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cell Culture Reagents, Cell Lines, Detection Kits, and Ligands.
  • Based on Assay Type, market is studied across Calcium Functional Assays, cAMP Functional Assays, Internalization Assays, Radioligand Binding and GTPYS Functional Assays, Trafficking Assays, and B-Arrestin Functional Assays.
  • Based on Application, market is studied across Cancer Research, Cardiovascular Research, CNS Research, Inflammation Research, Metabolic Research, and Respiratory Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of cardiovascular diseases across the globe
      • 5.1.1.2. Increasing expenditure for the development of novel pharmaceutical drugs and therapies
      • 5.1.1.3. Ongoing research activities to reduce the cancer burden
    • 5.1.2. Restraints
      • 5.1.2.1. Associated high cost with G-protein coupled receptors (GPCRs)
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in the number of regulatory approvals for novel drugs and therapies
      • 5.1.3.2. Emerging advances in the molecular understanding of G protein-coupled receptors
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals or trained subject expertise coupled with stringent approval norms
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. G-Protein Coupled Receptors Market, by Product

  • 6.1. Introduction
  • 6.2. Cell Culture Reagents
  • 6.3. Cell Lines
  • 6.4. Detection Kits
  • 6.5. Ligands

7. G-Protein Coupled Receptors Market, by Assay Type

  • 7.1. Introduction
  • 7.2. Calcium Functional Assays
  • 7.3. cAMP Functional Assays
  • 7.4. Internalization Assays
  • 7.5. Radioligand Binding and GTPYS Functional Assays
  • 7.6. Trafficking Assays
  • 7.7. B-Arrestin Functional Assays

8. G-Protein Coupled Receptors Market, by Application

  • 8.1. Introduction
  • 8.2. Cancer Research
  • 8.3. Cardiovascular Research
  • 8.4. CNS Research
  • 8.5. Inflammation Research
  • 8.6. Metabolic Research
  • 8.7. Respiratory Research

9. Americas G-Protein Coupled Receptors Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific G-Protein Coupled Receptors Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa G-Protein Coupled Receptors Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abalone Bio, Inc.
  • 2. Abcam PLC
  • 3. Addex Therapeutics
  • 4. Becton, Dickinson and Company
  • 5. BioInvenu,Inc.
  • 6. Cisbio Bioassays SAS
  • 7. Confo Therapeutics
  • 8. Corning Incorporated
  • 9. Crinetics Pharmaceuticals, Inc.
  • 10. Domain Therapeutics SA
  • 11. Enzo Life Sciences, Inc.
  • 12. Escient Pharmaceuticals
  • 13. Eurofins Scientific SE
  • 14. Merck KGaA
  • 15. Molecular Devices, LLC
  • 16. OKYO Pharma, Limited
  • 17. Orion Biotechnology
  • 18. OSE Immunotherapeutics
  • 19. PerkinElmer Inc.
  • 20. Promega Corporation
  • 21. QIAGEN GmbH
  • 22. Septerna
  • 23. Sosei Group Corporation
  • 24. Tectonic Therapeutic
  • 25. Teon Therapeutics, Inc.
  • 26. Thermo Fisher Scientific Inc.
  • 27. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. G-PROTEIN COUPLED RECEPTORS MARKET RESEARCH PROCESS
  • FIGURE 2. G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. G-PROTEIN COUPLED RECEPTORS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. G-PROTEIN COUPLED RECEPTORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. G-PROTEIN COUPLED RECEPTORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. G-PROTEIN COUPLED RECEPTORS MARKET DYNAMICS
  • TABLE 7. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CELL CULTURE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DETECTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LIGANDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CALCIUM FUNCTIONAL ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CAMP FUNCTIONAL ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY INTERNALIZATION ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RADIOLIGAND BINDING AND GTPS FUNCTIONAL ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY TRAFFICKING ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY B-ARRESTIN FUNCTIONAL ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CNS RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY INFLAMMATION RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY METABOLIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RESPIRATORY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. G-PROTEIN COUPLED RECEPTORS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 154. G-PROTEIN COUPLED RECEPTORS MARKET, FPNV POSITIONING MATRIX, 2023